Committed to deepening international medical services and cross–border healthcare cooperation, on July 2, Vice–Consul CHERNOVA ANNA (Чернова Анна Федоровна) of the Russian Consulate General in Guangzhou, along with her assistant Alisa, visited Guangzhou Royal Lee Cancer Hospital for a special research and exchange mission. They conducted an on–site inspection of the hospital’s international medical services, cross–border healthcare infrastructure, and distinctive oncology diagnosis and treatment technologies, building a bridge for SinoRussian crossborder medical cooperation and academic exchange.

Mr. YEO KIM SECK, Chief Executive Officer of Guangzhou Royal Lee Cancer Hospital, Vice President and Head of International Medical Services Ma Lanying, and Assistant to the President Tang Haibo, along with other hospital leaders, warmly received and accompanied the delegation throughout the visit, comprehensively presenting the hospital’s achievements in international operations and its highquality development.

The guests toured our hospital.

During the visit, Vice–Consul CHERNOVA ANNA and her delegation toured the hospital’s core clinical areas, gaining an immersive understanding of its standardized diagnosis and treatment workflows, refined service systems, high–end hardware facilities, and international clinical operation management models. From the application of cuttingedge oncology technologies to dedicated service processes for cross–border patients; from multilingual medical support to the construction of an international healthcare service system – the delegation spoke highly of our hospital’s professional, standardized, and globaloriented development philosophy, its wellestablished cross–border medical support capabilities, its leading oncology expertise, and its distinctive and differentiated industry positioning.

Vice–Consul CHERNOVA ANNA

At the subsequent special exchange symposium, our CEO Mr. YEO KIM SECK, on behalf of the entire hospital, extended a warm welcome to the delegation from the Russian Consulate General in Guangzhou and gave a detailed introduction to the hospital’s geographical advantages, development positioning, and strategic layout. He noted that Guangzhou Royal Lee Cancer Hospital is located in the core area of the ChinaSingapore Guangzhou Knowledge City – a key nationallevel bilateral cooperation platform between China and Singapore. The Knowledge City serves as a core hub for openingup, technological innovation, and international talent exchange in the GuangdongHong KongMacao Greater Bay Area, undertaking the important strategic mission of building an international talent free port and a demonstration zone for openingup and cooperation.

CEO Mr. YEO KIM SECK

Our hospital’s international and global medical service footprint, along with its fruitful cross–border diagnosis and treatment outcomes, drew great attention and keen interest from Vice–Consul CHERNOVA ANNA. In response to the delegation’s questions regarding the hospital’s core competitive advantages and its appeal to international patients, Vice President and Head of International Medical Services Ma Lanying provided a detailed and focused explanation. She stated that Royal Lee’s core competitiveness is rooted in multiple dimensions, including location advantage, industrial advantage, technological advantage, and service advantage.

Vice President and Head of International Medical Services Ma Lanying

At the location and industry level, the hospital leverages the core resource advantages of the ChinaSingapore Guangzhou Knowledge City International Innovative Drug Industrial Base, deeply integrating with the biomedical innovation industry chain and taking the lead in accessing global cuttingedge antitumor drugs, new technologies, and novel therapeutic options. At the technological level, the hospital precisely focuses on highend specialty oncology care, routinely offering a range of internationally advanced innovative therapies such as Y–90 microsphere interventional therapy, precision interventional minimally invasive therapy, and gene therapy, providing personalized, precise, and international treatment plans for patients with complex tumors. At the service level, the hospital has established a mature, integrated fullprocess service system covering international patient admission, multilingual care, cross–border medical coordination, and overseas followup, effectively removing all barriers to cross–border medical access.

CEO YEO KIM SECK presented souvenirs to Vice–Consul CHERNOVA  ANNA

During the meeting, the two sides reached preliminary consensus on multidimensional indepth cooperation. In the future, they will focus on deepening collaboration in areas such as mutual visits and training of Chinese and Russian medical staff, international medical education and academic exchange, cross–border MDT multidisciplinary consultations, joint introduction and clinical application of cuttingedge anticancer technologies, and interconnection of cross–border medical services. Together, they aim to build a regular platform for SinoRussian medical exchange and cooperation, promote mutual learning in oncology diagnosis and treatment technologies, share medical service resources, and help Russian patients access highquality international medical resources.